Cannabis as a risk factor for psychosis: Systematic review

Journal of Psychopharmacology

Volumn 19, Issue 2, 2005, Pages 187-194

  Semple, David M ^a   McIntosh, Andrew M ^a   Lawrie, Stephen M ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Cannabis; Case control; Psychosis; Psychotic symptoms; Schizophrenia; Systematic review

Indexed keywords

CANNABIS;

ADOLESCENT; ADULT; CANNABIS ADDICTION; CASE CONTROL STUDY; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; DISEASE EXACERBATION; FEMALE; HEALTH SURVEY; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MENTAL HEALTH; META ANALYSIS; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PSYCHOSIS; REVIEW; RISK FACTOR; SCHIZOPHRENIA; SYMPTOMATOLOGY; SYSTEMATIC REVIEW;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MARIJUANA SMOKING; MIDDLE AGED; PSYCHOTIC DISORDERS; RISK FACTORS;

EID: 17744379225     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/0269881105049040     Document Type: Review

References (44)

1. Agosti V, Nunes E, Levin F (2002) Rates of psychiatric comorbidity among U.S. residents with lifetime cannabis dependence. Am J Drug Alcohol Abuse 28: 643-652
2. Aleman A, Kahn R S, Selten J P (2003) Sex differences in the risk of schizophrenia: evidence from meta-analysis. Arch Gen Psychiatry 60: 565-571
3. Amorin P, Lecrubier Y, Weiller E, Hergueta T, Sheehan D (1998) DSM-III-R Psychotic disorders: procedural validity of the MINI International Neuropsychiatrie Interview (MINI). Concordance and causes for discordance with the CIDI. Eur Psychiatry 13: 26-34
4. Andreasson S, Allebeck P, Engstrom A, Rydberg U (1987) Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. Lancet 2: 1483-1486
5. Andreasson S, Allebeck P, Rydberg U (1989) Schizophrenia in users and nonusers of cannabis. A longitudinal study in Stockholm County. Acta Psychiatr Scand 79: 505-510
6. Arseneault L, Cannon M, Poulton R, Murray R, Caspi A, Moffitt TE (2002) Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ 325: 1212-1213
7. Arseneault L, Cannon M, Witton J, Murray R M (2004) Causal association between cannabis and psychosis: examination of the evidence. Br J Psychiatry 184: 110-117
8. Begg C B, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088-1101
9. Bowers M, Boutros N, D'Souza D C, Madonick S (2001) Substance abuse as a risk factor for schizophrenia and related disorders. Int J Mental Health 30: 33-57
10. Boydell J, Van Os J, Lambri M, Castle D, Allardyce J, McCreadie R G, Murray R M (2003) Incidence of schizophrenia in south-east London between 1965 and 1997. Br J Psychiatry 182: 45-49
11. Chambers R A, Krystal J H, Self D W (2001) A neurobiological basis for substance abuse comorbidity in schizophrenia. Biol Psychiatry 50: 71-83
12. D'Souza D C, Abi-Saad W, Madronick S, Wray Y, Forselius K, MacDougall L, Brush L, Cassello K. Krystal J H (2000) Cannabinoids and psychosis: evidence from studies with I.V. THC in schizophrenic patients and controls. Schizophr Res 41 (Suppl): 33
13. 3H]CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use. Neuroscience 103: 9-15
14. Degenhardt L, Hall W (2001) The association between psychosis and problematical drug use among Australian adults: findings from the National Survey of Mental Health and Well-Being. Psychol Med 31: 659-668
15. Degenhardt L, Hall W, Lynskey M (2001) Alcohol, cannabis and tobacco use among Australians: a comparison of their associations with other drug use and use disorders, affective and anxiety disorders, and psychosis. Addiction 96: 1603-1614
16. Degenhardt L, Hall W, Lynskey M (2003) Testing hypotheses about the relationship between cannabis use and psychosis. Drug Alcohol Depend 71: 37-48
17. Egger M, Smith G D, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634
18. Emrich H M. Leweke F M, Schneider U (1997) Towards a cannabinoid hypothesis of schizophrenia: cognitive impairments due to dysregulation of the endogenous cannabinoid system. Pharmacol Biochem Behav 50: 803-807
19. Farrell M, Boys A, Bebbington P, Brugha T, Coid J, Jenkins R, Lewis G, Meltzer H, Marsden J, Singleton N, Taylor C (2002) Psychosis and drug dependence: results from a national survey of prisoners. Br J Psychiatry 181: 393-398
20. Fergusson D M, Horwood L J, Swain-Campbell N R (2003) Cannabis dependence and psychotic symptoms in young people. Psychol Med 33: 15-21
21. Grech A, Takei N, Murray R (1998) Comparison of cannabis use in psychotic patients and controls in London and Malta. Schizophr Res 29: 22
22. Hall W, Degenhardt L (2000) Cannabis use and psychosis: a review of clinical and epidemiological evidence. Aust NZ J Psychiatry 34: 26-34
23. Hambrecht M, Hafner H (2000) Cannabis, vulnerability, and the onset of schizophrenia: an epidemiological perspective. Aust NZ J Psychiatry 34: 468-475
24. Kapur S (2003) Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry 160: 13-23
25. Leweke F M, Giuffrida A, Wurster U, Emrich H M, Piomelli D (1999) Elevated endogenous cannabinoids in schizophrenia. Neuroreport 10: 1665-1669
26. Loeber R, Yurgelun-Todd D (1999) Human neuroimaging of acute and chronic marijuana use: implications for frontocerebellar dysfunction. Hum Psychopharmacol Clin Exp 14: 291-304
27. Mathers D C, Ghodse A H (1992) Cannabis and psychotic illness. Br J Psychiatry 161: 648-653
28. Miller P, Lawrie S M, Hodges A, Clafferty R, Cosway R, Johnstone E C (2001) Genetic liability, illicit drug use, life stress and psychotic symptoms: preliminary findings from the Edinburgh study of people at high risk for schizophrenia. Soc Psychiatry Psychiatr Epidemiol 36: 338-342
29. Phillips L J, Curry C, Yung A R, Yuen H P, Adlard S, McGorry P D (2002) Cannabis use is not associated with the development of psychosis in an 'ultra' high-risk group. Aust NZ J Psychiatry 36: 800-806
30. Phillips P, Johnson S (2001) How does drug and alcohol misuse develop among people with psychotic illness? A literature review. Soc Psychiatry Psychiatr Epidemiol 36: 269-276
31. Potvin S, Stip E, Roy J Y (2003) Schizophrenia and addiction: An evaluation of the self-medication hypothesis. Encephale 29: 193-203
32. Rolfe M, Tang CM, Sabally S, Todd J E, Sam E B, Hatib N'Jie A B (1993) Psychosis and cannabis abuse in The Gambia. A case-control study. Br J Psychiatry 163: 798-801
33. Smit F, Bolier L. Cuijpers P (2003) Cannabis use as a probable causative factor in the later development of schizophrenia. Ned Tijdschr Geneeskd 147: 2178-2183
34. Smit F, Bolier L, Cuijpers P (2004) Cannabis use and the risk of later schizophrenia: a review. Addiction 99: 425-430
35. Stroup D F, Berlin J A, Morton S C, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. (2000) Meta-analysis of observational studies in epidemiology, a proposal for reporting. JAMA 283: 2008-2012
36. Tien A Y, Anthony J C (1990) Epidemiological analysis of alcohol and drug use as risk factors for psychotic experiences. J Nerv Ment Dis 178: 473-480
37. Tsapakis E-M, Guillin O, Murray R M (2003) Does dopamine sensitization underlie the association between schizophrenia and drug abuse? Curr Opin Psychiatry 16: S45-S52
38. Tsuang M T, Simpson J C, Kronfol Z (1982) Subtypes of drug abuse with psychosis. Demographic characteristics, clinical features, and family history. Arch Gen Psychiatry 39: 141-147
39. van Os J, Bak M, Hanssen M, Bijl R V, de Graaf R, Verdoux H (2002) Cannabis use and psychosis: a longitudinal population-based study. Am J Epidemiol 156: 319-327
40. Veen N D, Selten J P, van der Tweel I, Feller W G, Hoek H W, Kahn R S (2004) Cannabis use and age at onset of schizophrenia. Am J Psychiatry 167: 501-506
41. Verdoux H, Gindre C, Sorbara F, Tournier M, Swendsen J D (2003) Effects of cannabis and psychosis vulnerability in daily life: an experience sampling test study. Psychol Med 33: 23-32
42. Wilson W, Mathew R, Turkington T, Hawk T. Coleman R E, Provenzale J (2000) Brain morphological changes and early marijuana use: a magnetic resonance and positron emission tomography study. J Addict Dis 19: 1-22
43. Zammit S, Allebeck P, Andreasson S, Lundberg I, Lewis G (2002) Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. BMJ 325: 1199
44. 3H]SR141716A binding to cannabinoid CBl receptors is increased in the anterior cingulate cortex in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 28: 355-360